Silver Oak Securities, Inc Edwards Lifesciences Corp Transaction History

Silver Oak Securities, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$84.3 - $94.31 $81,855 - $91,575	971 New	971 $89,000
Q2 2023 Aug 02, 2023	BUY	$81.41 - $94.33 $398,990 - $462,311	4,901 New	4,901 $462,000
Q3 2022 Oct 20, 2022	BUY	$82.37 - $107.29 $151,807 - $197,735	1,843 Added 75.35%	4,289 $354,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $5,536 - $8,209	-64 Reduced 2.55%	2,446 $251,000
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $255,919 - $322,133	2,510 New	2,510 $311,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

Stay updated on Silver Oak Securities, Inc with notifications on news.